These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31792915)

  • 1. Myocardial perfusion imaging in cardiac sarcoidosis: A "sine qua non" for prognosis assessment?
    Benetos G; Giannopoulos AA
    J Nucl Cardiol; 2021 Aug; 28(4):1757-1759. PubMed ID: 31792915
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study.
    Martineau P; Pelletier-Galarneau M; Juneau D; Leung E; Nery PB; de Kemp R; Beanlands R; Birnie D
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2280-2281. PubMed ID: 31422126
    [No Abstract]   [Full Text] [Related]  

  • 3. The rate of myocardial perfusion recovery after steroid therapy and its implication for cardiac events in cardiac sarcoidosis and primarily preserved left ventricular ejection fraction.
    Koyanagawa K; Naya M; Aikawa T; Manabe O; Furuya S; Kuzume M; Oyama-Manabe N; Ohira H; Tsujino I; Anzai T
    J Nucl Cardiol; 2021 Aug; 28(4):1745-1756. PubMed ID: 31605274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating Myocardial Inflammation in Cardiac Sarcoidosis: Why, With What, and for How Long?
    Blankstein R; Divakaran S
    JACC Cardiovasc Imaging; 2022 Nov; 15(11):1956-1959. PubMed ID: 36357137
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac Sarcoidosis Detected by (18)F-Fluorodeoxyglucose Positron Emission Tomography.
    García JR; Sánchez R; Álvarez Moro FJ
    Rev Esp Cardiol (Engl Ed); 2016 Mar; 69(3):323. PubMed ID: 26507961
    [No Abstract]   [Full Text] [Related]  

  • 6. Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease.
    White JA; Rajchl M; Butler J; Thompson RT; Prato FS; Wisenberg G
    Circulation; 2013 Jun; 127(22):e639-41. PubMed ID: 23733970
    [No Abstract]   [Full Text] [Related]  

  • 7. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
    Brancato SC; Arrighi JA
    J Nucl Cardiol; 2011 Apr; 18(2):371-4. PubMed ID: 21318450
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic value of quantitative assessment of cardiac
    Lebasnier A; Legallois D; Bienvenu B; Bergot E; Desmonts C; Zalcman G; Agostini D; Manrique A
    Ann Nucl Med; 2018 Jun; 32(5):319-327. PubMed ID: 29560563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular thrombus on
    Norikane T; Mitamura K; Fujimoto K; Takami Y; Yamamoto Y; Nishiyama Y
    J Nucl Cardiol; 2021 Oct; 28(5):2403-2407. PubMed ID: 32533424
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
    Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced imaging of cardiac sarcoidosis.
    Schatka I; Bengel FM
    J Nucl Med; 2014 Jan; 55(1):99-106. PubMed ID: 24232870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).
    Manapragada PP; Andrikopoulou E; Bajaj N; Bhambhvani P
    Radiol Clin North Am; 2021 Sep; 59(5):835-852. PubMed ID: 34392922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evaluation of Cardiac Sarcoidosis with 18F-FDG PET.
    Al-Faham Z; Jolepalem P; Oliver Wong CY
    J Nucl Med Technol; 2016 Jun; 44(2):92-3. PubMed ID: 26271805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
    Paz YE; Bokhari S
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
    Ahmed AI; Abebe AT; Han Y; Alnabelsi T; Agrawal T; Kassi M; Aljizeeri A; Taylor A; Tleyjeh IM; Al-Mallah MH
    J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis.
    Waller AH; Blankstein R
    J Nucl Cardiol; 2014 Oct; 21(5):940-3. PubMed ID: 24942609
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluorodeoxyglucose Myocardial Accumulation to Assess Response to Immunosuppressive Treatment in Cardiac Sarcoidosis.
    Cooper LT; Reddy P
    JACC Cardiovasc Imaging; 2024 Jan; 17(1):59-61. PubMed ID: 37656116
    [No Abstract]   [Full Text] [Related]  

  • 19. Normal variant left ventricular lateral wall 18FDG uptake in cardiac sarcoid evaluations.
    Gecelter R; Van Tosh A; Nichols K
    J Nucl Cardiol; 2021 Feb; 28(1):375-376. PubMed ID: 32056102
    [No Abstract]   [Full Text] [Related]  

  • 20. Harnessing PET Imaging for Prognostic Precision in Cardiac Sarcoidosis.
    Chareonthaitawee P; Bois JP
    JACC Cardiovasc Imaging; 2024 Sep; 17(9):1098-1100. PubMed ID: 39237248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.